Gardasil Vaccine Lawsuit
The Lanier Law Firm provides legal assistance to those affected by Gardasil vaccine side effects. Our experienced team navigates complex litigation to seek justice and compensation for injuries caused by the vaccine. If you or a loved one has suffered adverse effects, we’re here to support you. Contact us at 800-723-3216 for guidance and advocacy in your Gardasil vaccine lawsuit.
Legally Reviewed By: Michelle Greene
Attorney | Pharmaceutical Liability
- Page Last Updated:
- September 16, 2024
Legally Reviewed By: Michelle Greene
Attorney | Pharmaceutical Liability
- Page Last Updated:
- September 16, 2024
Rachel Lanier:
The claims against Merck in our Gardasil litigation are based on injuries our client suffered when they went to get the HPV vaccine. Unfortunately, the Gardasil vaccine not only is not very effective against preventing HPV, but it actually causes autoimmune injuries.
One of the biggest ones is called POTS, which stands for Postural Orthostatic Tachycardia Syndrome. The other injury that a lot of our clients are suffering is actually primary or premature ovarian failure. So women are going and getting this vaccine when they’re young, ages nine to 39 is the primary age group, and then down the road finding out that because of them getting this vaccine, they’re not able to have children. So we are very passionate about these cases, and what Merck did is just, it’s such a shame.
Americans have filed dozens of lawsuits against Merck & Co. regarding its Gardasil HPV vaccine. Across the country, thousands of people have been seriously injured by this vaccine. Their injuries range from autoimmune disorders and premature ovarian failure to death. Learn more about the Gardasil vaccine, your legal rights, and as leaders in the litigation, how The Lanier Law Firm can help.
Gardasil Lawsuits: A Timeline
Rachel Lanier:
The state of the Gardasil litigation as of spring 2023 is that a lot of work and discovery is being done to comb through and uncover millions of pages of documents produced by Merck, do expert workup, and have the experts look into the client’s cases and explain the science to the judge, and eventually a jury. Bellwether discovery is about to ensue as summer 2023 bellwether selections are due. The Gardasil case is moving very quickly, and we are excited to get justice for our clients in the best way that we can.
Many Gardasil vaccine lawsuits are currently ongoing across the United States. Dozens of Gardasil lawsuits have been filed against Merck in federal court. The volume of Gardasil product liability cases is expected to grow very rapidly over the next year.
2024 Gardasil Lawsuit Updates
September 16, 2024
As of September 2024, the parties are near completion of plaintiff and doctor depositions for bellwether cases and have nearly completed liability depositions. General fact discovery closed in August 2024. Plaintiffs’ regulatory and causation expert reports have been served, and expert depositions will soon take place. Plaintiffs will also receive expert reports from Merck soon. Motion practice and briefing is ongoing.
June 11, 2024
As of June 2024, workup of 16 bellwether cases is underway, with trials expected to focus on injuries such as Postural Orthostatic Tachycardia Syndrome (POTS) and Premature Ovarian Insufficiency (POI). Discovery continues, and the parties are near completion of plaintiff and doctor depositions for bellwether cases, with liability depositions are actively underway. Expert discovery remains in progress, and expert reports and testimony are anticipated to be complete in August 2024. There are approximately 170 cases in the MDL, and more cases are expected as they clear the vaccine court process.
According to Rachel Lanier, “Serving as co-lead in the Gardasil MDL litigation allows Lanier Law Firm to champion our clients’ rights, seek justice for wrongdoing, and ensure accountability on a broader scale.”
May 7, 2024
Since 2022, Merck has faced nearly 200 HPV vaccine claims in the Gardasil Products Liability MDL. Plaintiffs allege they have suffered from serious autoimmune and neurological issues after receiving the vaccine. Plaintiffs and Defendants continue to engage in the discovery process, with depositions being scheduled and conducted. The litigation is expected to continue, with new cases potentially being added as more individuals come forward with claims related to Gardasil.
April 18, 2024
There are now a total of 143 cases in the Gardasil MDL with more likely to be filed in the coming weeks.
Merck requested that the MDL Judge dismiss all Gardasil lawsuits, arguing that the National Childhood Vaccine Injury Act should prevent plaintiffs’ failure-to-warn claims. However, MDL Judge Kenneth Bell partially denied this motion, allowing the litigation to move forward. Judge Bell ruled that claims of Merck’s negligent failure to inform health care providers about Gardasil’s risks and claims of fraudulent concealment are not entirely blocked by the Vaccine Act. This decision is important as it clears the way for the Gardasil litigation to progress.
March 8, 2024
Currently, over 140 complaints concerning Gardasil-related POTS injuries and other autoimmune side effects are pending within the federal court system. Additionally, a significant number of claims await resolution in the U.S. Vaccine Court, operating under the National Vaccine Injury Compensation Program.
These cases, unified by common questions of fact and law, were initially entrusted to U.S. District Judge Robert J. Conrad for streamlined discovery and pretrial proceedings. These proceedings are poised to include a series of early bellwether trials aimed at providing insights into jury responses to recurring evidence and testimony throughout the litigation. However, a recent development emerged on February 2 when the Judicial Panel on Multidistrict Litigation reassigned the litigation to U.S. District Judge Kenneth D. Bell, Sr., also serving in the Western District of North Carolina.
While the parties diligently prepare a subset of Gardasil cases for trial, legal representatives are actively investigating and filing new lawsuits on behalf of individuals who have suffered various complications from the HPV vaccine, including but not limited to POTS (Postural Orthostatic Tachycardia Syndrome) and Premature Ovarian Failure.
February 2, 2024
There are currently 132 cases in the Gardasil MDL, with more being filed every month. The first bellwether trials will focus on premature ovarian failure and postural orthostatic tachycardia syndrome. The first trial may occur in 2025. Plaintiffs’ leadership continue to conduct discovery and gather evidence.
On January 3, Judge Conrad issued a second Case Management Order, amending the discovery schedule. The new schedule calls for written discovery to be completed by February 15, with a deadline for general causation expert discovery to be completed by August 30 of this year.
2023 Gardasil Lawsuit Updates
December 4, 2023
Discovery and depositions are proceeding on Plaintiffs’ claims. That means that Plaintiffs’ lawyers are gathering the documents and testimony that they need for evidence. At this point, trials are expected to focus on two injuries: Postural Orthostatic Tachycardia Syndrome and Premature Ovarian Failure.
September 26, 2023
Last week, on September 26th, a status hearing was held with counsel for both sides in the Gardasil MDL to provide the Judge with several updates. These matters included how the parties are meeting and conferring to resolve issues in the recent motion to compel filed by the plaintiffs. The hearing also provided the MDL Judge with updates on the bellwether cases, as well as limits on the scope of discovery.
The two types of Gardasil claims being prepared for trial in the MDL are: POI (Premature Ovarian Insufficiency) and POTS (Postural Orthostatic Tachycardia Syndrome).
September 18, 2023
Per Attorney Michelle Greene, “Sixteen bellwether cases were selected jointly by plaintiffs and defendants for preliminary trials, offering insight into how juries may respond to evidence and testimony. Recently, 13 of the 16 plaintiffs selected as bellwether candidates have filed amended complaints, per the latest case management conference on August 29. With about 100 cases in the MDL, there are many more claims making their way through Vaccine Court and likely to be filed in the MDL in the coming months.”
July 18, 2023
The parties file a status report proposing that the status conference scheduled for July 25, 2023, be canceled due to FRCP 30(b)(6) depositions being scheduled on July 27, 2023, and August 2, 2023.
A 30(b)(6) deposition is a hearing during which witnesses will be required to testify to everything they know under oath. The parties, in any case requiring these types of depositions, are expected to agree ahead of time on what topics will be covered, and the side being deposed is expected to fully prepare the witnesses. Full disclosure is expected at these depositions.
July 17, 2023
Three new cases have been added to the MDL since last month, bringing the total to 89 cases.
June 23, 2023
Thirteen of the 16 plaintiffs in the Initial Bellwether Pool amended their complaints.
June 23, 2023
Per Managing Attorney Rachel Lanier, “Cases continue to be filed, and discovery is ongoing. Bellwether selection has taken place.” The 16 bellwether cases selected will be narrowed down to 6 for trials beginning in 2024.
May 15, 2023
Cases continue to be filed and transferred to the MDL every month. When the cases were initially consolidated to the MDL in August of 2022, 31 cases were pending. As of today, 86 cases against Merck have been filed and transferred to the MDL and remain open.
By submitting this form, you agree to our terms & conditions. Please read full disclaimer here.
March 20, 2023
In an important victory for the plaintiffs, Judge Conrad granted the plaintiffs’ motion to compel Merck to provide plaintiffs’ attorneys with access to its entire database of adverse reactions to the HPV vaccine, including the Merck Adverse Event Reporting and Review System (MARRS).
April 17, 2023
The total number of cases against Merck pending in the MDL has increased by four since last month, with 82 cases pending.
March 17, 2023
As cases continue to be filed by unsuspecting patients who have been left with autoimmune disorders after receiving a vaccine that was marketed as safe, 78 cases brought by injured victims and their parents are now pending in the MDL.
March 10, 2023
In the First Case Management Order, the court set the schedule for the next steps in the multidistrict litigation.
Bellwether Trial Selection
Bellwether trials are test trials used to gauge the outcome of a typical case to provide the remaining parties with guidance on how the cases should resolve. This provides an efficient method of resolving a large number of cases without the necessity of each individual case having to go to trial.
It prevents the court system from becoming overburdened and provides guidance for settlement negotiations. If plaintiffs in the bellwether cases receive favorable verdicts, it will incentivize Merck to offer fair and reasonable settlements.
In the first Case Management Order, Judge Conrad ordered the initial pool of 16 bellwether cases to be selected by June 1, 2023. The bellwether cases selected must have been transferred to the MDL on or before February 28, 2023.
Two of the pending cases were individually filed in the Western District of North Carolina before being transferred to the MDL. Judge Conrad ordered these two cases to be included in the initial bellwether pool. These cases are Hilton v. Merck and Co., (Case No. 5:22-CV-00030) and Bergin v. Merck & Co. (Case No. 3:22-CV-00117).
Plaintiffs’ attorneys and defendants’ attorneys will each select five cases to be included in the initial bellwether pool in addition to these two. The remaining four cases will be selected at random by the court.
Case Motions
The court affirmed the schedule the parties agreed to for any Daubert or summary judgment motions that may be filed in the case.
A Daubert motion is a motion to disqualify an expert for the purpose of excluding testimony by that expert. A summary judgment motion is a motion to dismiss a case before it goes to trial. Both of these motions are common in MDL lawsuits. Merck is expected to file a motion for summary judgment on the basis of federal preemption.
Federal preemption is a claim that federal law supersedes a state law that allows a plaintiff to sue. In such a motion, the defendants will likely argue that the National Childhood Vaccine Injury Act prohibits a lawsuit based on design defect claims against vaccine makers. They may base this on the Supreme Court decision in Bruesewitz v. Wyeth.
In this case, the Supreme Court ruled in favor of the drug maker. However, it did not prohibit lawsuits against drugmakers on the basis of negligence, as is being alleged in this litigation.
Judge Conrad ordered the following deadlines for these motions:
Plaintiffs’ general causation expert reports
March 14, 2024
Defendants’ general causation expert reports
April 11, 2024
Expert witness depositions/discovery
May 23, 2024
Daubert motions
July 8, 2024
Motions for summary judgment
July 8, 2024
Opposition to motions filed
August 22, 2024
Replies in support of motions filed
September 23, 2024
Case Discovery
Case discovery is the investigation of the facts of the case, in which each party investigates the other party’s claims. It includes gathering documentation, interviewing witnesses, and completing depositions. Judge Conrad has ordered a written discovery deadline of December 14, 2023 and a fact discovery deadline of February 15, 2024.
Additional discovery deadlines have been set, beginning four months after the court has issued a ruling on a motion for summary judgment, if filed. If the court grants a summary judgment, the court will determine the next steps at that time.
If the court does not grant the motion, the remaining fact discovery for the 16 bellwether cases will be due in four months. The court further ordered that over the course of the following 164 days, the initial pool of 16 bellwether cases will be narrowed down to 6.
February 16, 2023
The number of cases pending in the MDL has more than doubled since the cases were initially transferred in August. The number of pending cases to date is 65.
January 27, 2023
Judge Conrad has issued the third pretrial order in the MDL. According to the order, the initial bellwether cases will be a select pool of cases in which the plaintiffs allege one of the following two injuries:
- Postural orthostatic tachycardia syndrome
- Primary ovarian failure or insufficiency
Judge Conrad granted a motion to dismiss the cases against Watchung Pediatrics, Susan P. Korb, APN, and Vineetha A. Alias, D.O. with prejudice. As pre-agreed by counsel, both sides will absorb their own attorney costs. The court affirmed that the claims against Merck & Co., Inc. will move forward and are unaffected by this order.
January 17, 2023
The number of cases in the MDL since the August 22, 2022 centralization has nearly doubled, with 60 cases pending and many more expected.
2022 Gardasil Lawsuit Updates
December 19, 2022
The defense filed a motion to dismiss the case against Watchung Pediatrics, Susan Korb APN, and Vioneetha Alias, D.O. (a pediatrician) on the grounds that plaintiffs failed to timely file an Affidavit of Merit in compliance with New Jersey law, and the time to do so has expired.
December 15, 2022
The number of cases pending in the MDL has increased to 59 as of today’s date.
November 18, 2022
Plaintiffs’ attorneys filed a motion to compel Merck to turn over the entirety of its Adverse Event Reporting and Review System, which will provide data on adverse events that were reported to Merck and when Merck became aware of these events. This motion was filed in response to Merck’s refusal to provide this information.
November 15, 2022
New cases are being filed and transferred to the MDL every month. As of today’s date, 57 cases are pending.
October 14, 2022
In less than two months, the number of cases pending in the MDL has grown from 31 to 55.
October 13, 2022
In the Second Pretrial Order in the case, Judge Conrad selected the plaintiff’s co-lead and liaison counsel. The Lanier Law Firm’s Rachel Lanier was among the three attorneys selected as co-lead counsel. This is an important role in an MDL case because the co-lead counsel determines the strategy for all the cases in the MDL.
September 20, 2022
Attorneys for Merck & Co., filed a position statement outlining their defense, claiming that the vaccine is safe, effective, and covered by the National Childhood Vaccine Injury Act. Under this act. According to Merck, the court should dismiss the lawsuits on this basis.
Merck’s attorneys further allege that there is no scientific evidence to support that Gardasil causes the conditions alleged by the defendants. Merck has requested that the court limit discovery and provide a speedy process to dismiss claims.
September 20, 2022
Attorneys for the plaintiffs filed the Plaintiffs’ Position Statement today. In the statement, plaintiffs state that they are pursuing damages on the following grounds:
- Negligence
- Failure to warn of Gardasil’s risk of autoimmune and neurological injuries
- Manufacturing defect
- Breach of warranty
- Common law fraud
- Violation of state consumer laws
Plaintiffs allege that Merck knowingly engaged in an active campaign to conceal and downplay these risks and actively misrepresented the efficacy of the product. Merck has refused to give plaintiffs access to its adverse event reporting database, according to the position statement.
Attorneys for the plaintiffs assert that court precedent places the burden on the defendant, not the plaintiffs, to prove that preemption applies. This would require the defendants to prove that they could not change the label because federal law prohibited it.
September 15, 2022
In just over a month, the number of claims pending in the MDL has risen from 31 cases to 49.
August 4, 2022
On August 4, 2022, the United States Judicial Panel on Multidistrict Litigation granted the motion to centralize the Gardasil cases against Merck. As of today’s date, 31 actions are pending in 22 districts. These cases will be transferred to the Honorable Judge Robert J. Conrad, Jr. of the Western District of North Carolina.
The court determined that centralization in the Western District of North Carolina would be appropriate on the basis that it is convenient and readily available to parties on both sides of the case. Two pending actions in the litigation were initially filed in this jurisdiction.
April 4, 2022
Plaintiffs in the litigation against Merck for autoimmune effects of its vaccine Gardasil filed a motion to transfer the cases to MDL. All plaintiffs supported centralizing the cases in MDL. In the motion, the plaintiffs proposed that the case be transferred to one of the following districts:
- The District of Arizona
- The Western District of Wisconsin
- The Central District of California
- The Middle District of Louisiana
The defendants opposed centralization but proposed that if centralization must occur, the cases be transferred to one of the following districts:
- The District of Connecticut
- The Eastern District of Michigan
Merck's Potential Misrepresentation of Gardasil's Efficacy
In 2006, Merck began heavily marketing a misleading campaign that its Gardasil vaccine was a safe and effective way to prevent HPV infections. However, evidence has arisen that the Gardasil vaccine causes serious and disabling side effects. Plaintiffs claim the Gardasil vaccine’s manufacturer did not provide adequate warning of possible side effects associated with the product and that Merck fraudulently concealed evidence about the health risks of the vaccine while at the same time misrepresenting that Gardasil could prevent cervical cancer. Specifically, lawsuits have been filed against Merck for issues such as failure to warn, manufacturing defect, and negligence.
The Vaccine Act
The Vaccine Act, or the National Childhood Vaccine Act of 1986, prohibits certain failures to warn and design defect claims against manufacturers. However, federal law does allow for negligence claims. Passed in 1986, the Vaccine Act created a no-fault compensation program for children suffering injuries from vaccines.
You may file a petition under the Vaccine Act if the injury in question:
- Lasted more than six months after vaccination; or
- Resulted in inpatient hospitalization and surgery; or
- Resulted in the patient’s death.
If the injury meets one of the above specifications, then you must file your petition within the following deadlines:
- You must file injuries within three years of the first symptom or the significant aggravation of the injury.
- Wrongful death cases must be filed within two years of the death and four years of the first symptom or the significant aggravation of the injury.
In some limited cases, the Vaccine Program may extend a deadline.
Generally, Gardasil and HPV vaccines are covered under the Vaccine Act.
What Is the Gardasil Vaccine?
The Gardasil vaccine developed by Merck was marketed to protect against the human papillomavirus (HPV) and can be received by anyone from ages 9 through 26 years. HPV is the most common sexually transmitted infection in the U.S. More than 150 strains of the virus exist, and while most infections resolve on their own, more than 40 strains can cause cancer. The U.S. Food and Drug Administration (FDA) approved the first-generation Gardasil vaccine in 2006 and the newer Gardasil 9 vaccine, which aims to protect against more virus strains, in 2014. Merck obtained a fast-track FDA approval for Gardasil with deceptive research trials, concealing material facts about the effectiveness and safety of Gardasil.
Gardasil Long-Term Side Effects
Scientific research has found that Gardasil induces and increases the risk of many long-term side effects related to autoimmune disorders and reproductive disorders, including:
- Postural orthostatic tachycardia syndrome (POTs)
- Premature and/or primary ovarian failure and insufficiency
- Reproductive disorders
- Guillain–Barré syndrome
- Fibromyalgia
- Dysautonomia
- Orthostatic Intolerance
- Myalgic Encephalomyelitis/Chronic fatigue syndrome
- Chronic regional pain syndrome
- Migraines/Severe headaches
- Persistent gastrointestinal discomfort
- Widespread pain of a neuropathic character
- Encephalitis syndrome
- Autonomic dysfunction
- Joint pain
- Brain fog
Why Should You Choose The Lanier Law Firm for Your Gardasil Lawsuit?
If you or a loved one suffered side effects from Merck’s Gardasil vaccine, a trusted legal team can help. The Lanier Law Firm wants to hear your story and help you pursue legal action. We know what it takes to stand up to big pharma companies like Merck and win.
We won the first-ever verdict against Merck, leading to a $4.85 billion national settlement over Merck’s drug Vioxx.
At The Lanier Law Firm, we understand pharmaceutical liability, and we know Gardasil.
Frequently Asked Questions
Understanding key facts and context about the Gardasil vaccine, recalls, and other lawsuits will help you consider your options if you suspect the vaccine has caused you or your loved one to experience injury or adverse side effects.
Rachel Lanier:
In order to file a Gardasil lawsuit, because it’s a vaccine, first, a claim has to go through the vaccine program that is set up by the US government. And we have lawyers who can help consult through that process. After that ends up happening, a lawsuit in civil court can be filed, and right now the multi-district litigation case is pending in North Carolina at this time.
Evan Janush:
And on this subject, Rachel, we should probably also discuss the notion that many of the victims of Gardasil are children, teenagers, and young folks, some of whom may not have reached the age of majority, who have to have their parent, mother, or father or guardian file on their behalf and retain a law firm such as the Linear Law Firm on behalf of that minor child.
Rachel Lanier:
That’s absolutely true. It’s devastating to see what has happened to our clients and their children. And a lot of the times we’re working closely with parents to protect their children and their children’s rights to pursue a legal claim moving forward.
Is there a lawsuit against Gardasil?
Multiple lawsuits against Merck for serious side effects stemming from its Gardasil vaccine are pending. There are now approximately 60 active Gardasil lawsuits pending in the Gardasil class action MDL in the Western District of North Carolina. An influx of new cases are expected to be filed at some point in the near future as previously filed Gardasil claims clear the Vaccine Injury Compensation Program process.
Why was Gardasil recalled?
On December 16, 2013, the CDC was informed by Merck that the company planned to implement a voluntary recall of one lot (lot J007354) of Gardasil Vaccine due to the potential for a small number of vials to contain glass particles as a result of breakage during the manufacturing process. Then again, in October 2020, Merck issued an urgent voluntary vaccine recall of Gardasil 9 belonging to Lot R030456. Merck recalled Gardasil, a temperature-sensitive vaccine because units were stored at inappropriate temperatures.
What is the problem with the Gardasil vaccine?
Many have complained of negative side effects after receiving Merck’s Gardasil vaccine. Complaints range from dizziness and fainting to developing autoimmune disorders and even death. According to the Vaccine Adverse Event Reporting System (VAERS), there have been 64,000 adverse events reported against Gardasil in the United States alone. Of these, nearly 10,000 have been serious negative events, including 547 deaths.
Was Gardasil taken off the market?
After the FDA fast-track approval of the Gardasil 9 vaccine in 2006, the original Gardasil vaccine was phased out of the U.S. Market; and is no longer available for sale in the United States. The last doses of Gardasil-4 expired on May 1, 2017. Since late 2016, Gardasil 9 is the only HPV vaccine distributed in the U.S.
Schedule a Free Consultation With Our
Winning Gardasil Lawyers Today
If Merck’s Gardasil vaccine against HPV has harmed you or a loved one, you may have legal options even if you’re experiencing Gardasil side effects years later. The Lanier Law Firm is committed to holding pharmaceutical companies accountable. Schedule a free consultation with our experts to get answers to your questions and more information about your options.
By submitting this form, you agree to our terms & conditions. Please read the full disclaimer
